rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-4-26
|
pubmed:abstractText |
Exposure of the ocular surface to mustard gas chemical warfare leads to a destructive inflammatory reaction. Both steroids and a novel metalocomplex free radical scavenger, zinc desferrioxamine (Zn/DFO), have been shown to be effective separately in reducing ocular damage. The purpose of the present study was to investigate whether the effectiveness of both medications applied simultaneously is superior to the effectiveness of either one applied alone.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemical Warfare Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Deferoxamine,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radical Scavengers,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Mechlorethamine,
http://linkedlifedata.com/resource/pubmed/chemical/Methionine Sulfoxide Reductases,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Zinc,
http://linkedlifedata.com/resource/pubmed/chemical/methionine sulfoxide reductase,
http://linkedlifedata.com/resource/pubmed/chemical/zinc-desferrioxamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0146-0404
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1640-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15851563-Animals,
pubmed-meshheading:15851563-Atrophy,
pubmed-meshheading:15851563-Burns, Chemical,
pubmed-meshheading:15851563-Chemical Warfare Agents,
pubmed-meshheading:15851563-Corneal Diseases,
pubmed-meshheading:15851563-Corneal Neovascularization,
pubmed-meshheading:15851563-Corneal Opacity,
pubmed-meshheading:15851563-Deferoxamine,
pubmed-meshheading:15851563-Dexamethasone,
pubmed-meshheading:15851563-Drug Therapy, Combination,
pubmed-meshheading:15851563-Eye Burns,
pubmed-meshheading:15851563-Free Radical Scavengers,
pubmed-meshheading:15851563-Glucocorticoids,
pubmed-meshheading:15851563-Intraocular Pressure,
pubmed-meshheading:15851563-Iris,
pubmed-meshheading:15851563-Mechlorethamine,
pubmed-meshheading:15851563-Methionine Sulfoxide Reductases,
pubmed-meshheading:15851563-Organometallic Compounds,
pubmed-meshheading:15851563-Oxidoreductases,
pubmed-meshheading:15851563-Rabbits,
pubmed-meshheading:15851563-Reactive Oxygen Species,
pubmed-meshheading:15851563-Wound Healing,
pubmed-meshheading:15851563-Zinc
|
pubmed:year |
2005
|
pubmed:articleTitle |
Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids.
|
pubmed:affiliation |
Department of Ophthalmology, Assaf Harofeh Medical Center, Zrifin 73000, Israel. ymorad@013.net.il
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|